UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 13D and 13G filings for Aileron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-05 5:17 pm Sale | 2024-11-04 | 13G | Aileron Therapeutics, Inc. ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 960,665 4.400% | -851,962 (-47.00%) | Filing |
| 2024-03-05 7:14 pm Purchase | 2024-02-28 | 13G | Aileron Therapeutics, Inc. ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,812,627 6.200% | 1,812,627 (New Position) | Filing |